• 1
    Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users’ guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995;274:18001804.
  • 2
    Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461472.
  • 3
    Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134:657662.
  • 4
    Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995;311:11451148.
  • 5
    Altman DG, Bland JM. How to randomise. BMJ 1999;319:703704.
  • 6
    Enas GG, Enas NH, Spradin CT, Wilson MG, Wiltse CG. Baseline comparability in clinical trials. Drug Inf J 1990;24:541548.
  • 7
    Treasure T, MacRae KD. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ 1998;317:362363.
  • 8
    Frew AJ, White PJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 1999;104:267270.
  • 9
    Malling HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002;2:523531.
  • 10
    Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001;285:20002003.
  • 11
    Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437448.
  • 12
    Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:412.